A randomized, non-inferiority trial of oral minoxidil 1.25 mg versus 5% topical minoxidil solution in the treatment of female pattern hair loss

Dermotology unit, King Chulalongkorn Memorial Hospital0 个研究点目标入组 44 人开始时间: 2020年12月22日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1. Female patients, aged 18-65 year who were diagnosed with female pattern hair loss
•2. History, clinical and dermoscope showed Savin scale I-4, II-1 and II-2
•3. No treatment before or stop previous treatment at least 3 months prior to study

•1. patients who have other co-morbidity diseases which effect to hair density such as any malignancy, anemia, hypothyroidism/hyperthyroidism, AIDS and autoimmune connective tissue disease and who have cardiovascular disease
•2. patients who have other scalp disease ex. seborrheic dermatitis, scalp psoriasis, tinea capitis.
•3. patients who have history of hair transplantation or have large scar on scalp
•4. patients who have history of minoxidil allergy
•5. pregnancy or lactation women
•6. on Hormonal therapy or spironolactone

发起方

Dermotology unit, King Chulalongkorn Memorial Hospital